Clinical Trial

A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy

Name: A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy — clinical trial record (NCT07723963)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

This study is being conducted to evaluate the safety and efficacy of JZP926 capsule in participants with Juvenile Myoclonic Epilepsy (JME).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-07-20.

Trial Details

NCT Number	NCT07723963
Lead Sponsor	Jazz Pharmaceuticals
Conditions	Juvenile Myoclonic Epilepsy
Enrollment	260 participants
Start Date	2026-09-01
Primary Completion	2028-08-01 (estimated)
Study Completion	2028-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-24